|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,251.30 INR | -1.22% |
|
+0.78% | +10.62% |
| 03/08 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 31/07 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| Market Cap | 64TCr 666.14Cr 576.67Cr 539.02Cr 492.63Cr 928.33Cr 942.85Cr 6.32TCr 2.48TCr 32TCr 2.5TCr 2.45TCr 1,05900Cr | P/E 2026 |
44.2x | P/E 2027 * | 27.4x |
|---|---|---|---|---|---|
| Enterprise Value | 60TCr 624.94Cr 541.01Cr 505.68Cr 462.17Cr 870.92Cr 884.54Cr 5.93TCr 2.33TCr 30TCr 2.35TCr 2.3TCr 99TCr | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.7x |
| Free-Float |
51.04% | Yield 2026 |
0.12% | Yield 2027 * | 0.17% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -1.22% | ||
| 1 week | +0.78% | ||
| Current month | +0.78% | ||
| 1 month | -0.70% | ||
| 3 months | -4.86% | ||
| 6 months | +14.02% | ||
| Current year | +10.62% |
| 1 week | 2,200 |  | 2,297.8 |
| 1 month | 2,162 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.22% | +0.78% | +11.47% | +171.70% | 675.79Cr | |
| -0.03% | -2.32% | +22.53% | +68.67% | 4.9TCr | |
| -1.14% | +13.15% | +60.80% | +127.29% | 4.23TCr | |
| +0.27% | -0.37% | -1.22% | +15.93% | 1.24TCr | |
| +0.43% | -0.69% | +19.53% | +69.15% | 1.17TCr | |
| +3.84% | +0.19% | +30.98% | +140.74% | 911.81Cr | |
| +3.81% | +8.39% | +22.04% | +39.32% | 714.94Cr | |
| +1.62% | +1.47% | +41.67% | -12.77% | 709.32Cr | |
| +0.03% | +8.29% | -24.59% | +28.71% | 595.19Cr | |
| +0.49% | +1.18% | +34.57% | +100.44% | 457.87Cr | |
| Average | +0.41% | +2.10% | +21.78% | +74.92% | 1.56TCr | |
| Weighted average by Cap. | -0.07% | +1.66% | +30.21% | +83.43% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 15TCr 160.54Cr 138.98Cr 129.9Cr 118.73Cr 223.73Cr 227.23Cr 1.52TCr 597.74Cr 7.66TCr 602.81Cr 589.66Cr 26TCr | 17TCr 176.07Cr 152.42Cr 142.47Cr 130.21Cr 245.37Cr 249.21Cr 1.67TCr 655.56Cr 8.4TCr 661.13Cr 646.71Cr 28TCr |
| Net income | 2.05TCr 22Cr 19Cr 17Cr 16Cr 30Cr 30Cr 204.27Cr 80Cr 1.03TCr 81Cr 79Cr 3.42TCr | 2.31TCr 24Cr 21Cr 20Cr 18Cr 34Cr 34Cr 229.93Cr 90Cr 1.16TCr 91Cr 89Cr 3.85TCr |
| Net Debt | -3.93TCr -41Cr -36Cr -33Cr -30Cr -57Cr -58Cr -390.94Cr -153.4Cr -1.97TCr -154.7Cr -151.33Cr -6.55TCr | -1.45TCr -15Cr -13Cr -12Cr -11Cr -21Cr -21Cr -143.99Cr -57Cr -724.06Cr -57Cr -56Cr -2.41TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | ₹2,251.30 | -1.22% | 2,57,787 |
| 07/26/07 | ₹2,279.10 | +0.40% | 4,37,610 |
| 06/26/06 | ₹2,270.00 | +0.49% | 5,56,267 |
| 05/26/05 | ₹2,259.00 | +1.53% | 3,88,492 |
| 04/26/04 | ₹2,225.00 | -0.22% | 4,44,946 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
